IRIS
GIACOMELLI, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 13.228
NA - Nord America 4.384
EU - Europa 1.740
SA - Sud America 1.542
AF - Africa 147
OC - Oceania 46
Continente sconosciuto - Info sul continente non disponibili 2
AN - Antartide 1
Totale 21.090
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 7.715
US - Stati Uniti d'America 4.180
CN - Cina 2.166
HK - Hong Kong 2.083
BR - Brasile 1.192
VN - Vietnam 708
GB - Regno Unito 609
IT - Italia 318
DE - Germania 220
AR - Argentina 151
IN - India 139
CA - Canada 117
NL - Olanda 104
ID - Indonesia 101
EC - Ecuador 70
ZA - Sudafrica 66
JP - Giappone 63
MX - Messico 62
UA - Ucraina 62
BD - Bangladesh 55
TR - Turchia 53
FR - Francia 48
PL - Polonia 44
ES - Italia 42
AU - Australia 41
RU - Federazione Russa 40
CO - Colombia 39
FI - Finlandia 36
PY - Paraguay 30
AT - Austria 29
SE - Svezia 29
CL - Cile 25
CZ - Repubblica Ceca 25
PE - Perù 21
PT - Portogallo 20
EG - Egitto 17
MA - Marocco 17
IQ - Iraq 15
PK - Pakistan 15
KZ - Kazakistan 13
IL - Israele 12
RO - Romania 12
IR - Iran 11
LT - Lituania 11
BG - Bulgaria 9
DK - Danimarca 9
TN - Tunisia 9
KE - Kenya 8
SA - Arabia Saudita 8
UZ - Uzbekistan 8
CH - Svizzera 7
GR - Grecia 7
IE - Irlanda 7
AL - Albania 6
SK - Slovacchia (Repubblica Slovacca) 6
TH - Thailandia 6
UY - Uruguay 6
AE - Emirati Arabi Uniti 5
DO - Repubblica Dominicana 5
EE - Estonia 5
JO - Giordania 5
LB - Libano 5
LU - Lussemburgo 5
LV - Lettonia 5
OM - Oman 5
SN - Senegal 5
BE - Belgio 4
GH - Ghana 4
GT - Guatemala 4
HN - Honduras 4
KW - Kuwait 4
RS - Serbia 4
SI - Slovenia 4
VE - Venezuela 4
AF - Afghanistan, Repubblica islamica di 3
AZ - Azerbaigian 3
BO - Bolivia 3
IS - Islanda 3
KR - Corea 3
PH - Filippine 3
QA - Qatar 3
YT - Mayotte 3
BA - Bosnia-Erzegovina 2
BW - Botswana 2
CG - Congo 2
CY - Cipro 2
DZ - Algeria 2
HU - Ungheria 2
JM - Giamaica 2
LA - Repubblica Popolare Democratica del Laos 2
MK - Macedonia 2
MY - Malesia 2
NC - Nuova Caledonia 2
NG - Nigeria 2
NP - Nepal 2
NZ - Nuova Zelanda 2
PA - Panama 2
SV - El Salvador 2
TL - Timor Orientale 2
TW - Taiwan 2
Totale 21.059
Salva come PNG Salva come JPEG
Città #
Hong Kong 2.060
Singapore 1.468
Ashburn 1.224
Hefei 1.101
Boardman 616
San Jose 611
London 526
Shanghai 350
Dallas 331
Beijing 292
Ho Chi Minh City 268
Council Bluffs 195
Hanoi 142
Los Angeles 121
São Paulo 100
Pune 94
San Francisco 92
Amsterdam 75
Rome 62
Munich 61
Toronto 61
Washington 51
Santa Clara 48
Seattle 48
Tokyo 46
New York 44
Warsaw 37
Haiphong 35
Brooklyn 30
Brasília 27
Da Nang 26
Rio de Janeiro 26
Ankara 25
Johannesburg 24
Montreal 24
Stockholm 24
Turku 23
Biên Hòa 22
Chicago 22
Guayaquil 22
Mexico City 22
Quito 21
Curitiba 20
Thái Bình 20
West Jordan 20
Brno 19
Naples 19
Boston 18
Guangzhou 18
Hải Dương 18
Porto Alegre 18
Bari 17
Buenos Aires 17
Jinan 17
Frankfurt am Main 16
Atlanta 15
Belo Horizonte 15
Campinas 15
Chennai 15
Manchester 15
Phoenix 15
Vienna 15
Guarulhos 14
Lima 14
Can Tho 13
Cape Town 13
Jakarta 13
Manaus 13
Melbourne 13
Sydney 13
Helsinki 12
Lấp Vò 12
Charlotte 11
Hortolândia 11
Paris 11
Qingdao 11
Barcelos 10
Milan 10
Ninh Bình 10
Salvador 10
Secaucus 10
Asunción 9
Cairo 9
Hanover 9
Nuremberg 9
Ribeirão Preto 9
Santo André 9
The Dalles 9
Bogotá 8
Canberra 8
Changsha 8
Fortaleza 8
Goiânia 8
Hangzhou 8
Jaguariúna 8
Joinville 8
Maceió 8
Natal 8
Osasco 8
Bắc Giang 7
Totale 11.221
Salva come PNG Salva come JPEG
Nome #
Fibroblast expression of CD248 may contribute to exacerbate microvascular damage during systemic sclerosis 221
------- 218
Adipocytokines in Rheumatoid Arthritis: The Hidden Link between Inflammation and Cardiometabolic Comorbidities 215
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments 214
Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study 206
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis 200
Efficacy and safety of imatinib mesylate in systemic sclerosis. A systematic review and meta-analysis 192
AB0550 PHENOTYPE OF BIOPSY-PROVEN PATIENTS WITH PRIMARY SJÖGREN SYNDROME LACKING RO AUTOANTIBODIES: HIGH FREQUENCY OF DRYNESS SYMPTOMS WITH LOW SYSTEMIC ACTIVITY (BIG DATA SJÖGREN PROJECT) 189
Adipose stromal vascular fraction and regenerative therapy in SSc: Response to the article by Magalon et al 185
Cytokine profile, ferritin, and multi-visceral involvement characterise macrophage activation syndrome during adult-onset Still's disease 180
A comprehensive review on adult onset Still's disease 174
Clinical characteristics of obese patients with adult-onset Still's disease. Data from a large multicentre cohort 173
Cardiometabolic multimorbidity may identify a more severe subset of rheumatoid arthritis, results from a “real-life” study 172
Impaired immunogenicity to COVID-19 vaccines in autoimmune systemic diseases. High prevalence of non-response in different patients' subgroups 172
Aberrant expression of IL-22RA1 on hematopoietic cells as immunologically signature of primary sjogren’s syndrome and sjogren-associated non-hodgkin lymphomas 169
AB0458 A PHASE II RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PROOF OF CONCEPT STUDY OF ORAL SELETALISIB IN PATIENTS WITH PRIMARY SJÖGREN’S SYNDROME (PSS) 167
A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis 166
A3.1 Pathogenic role of IL-17 producing double negative (DN) T cells in primary sjögren’s syndrome 159
Clinical correlates of a subset of anti-fibroblast antibodies in systemic sclerosis 158
Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing Therapies 157
Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry 156
2-Arachidonoylglycerol Reduces the Production of Interferon-Gamma in T Lymphocytes from Patients with Systemic Lupus Erythematosus 136
Adult-onset Still's disease with elderly onset: results from a multicentre study 135
Bosentan effect on echocardiographic systolic pulmonary arterial pressure in systemic sclerosis-related pulmonary hypertension: a systematic review and metanalysis 129
2021 update of the EULAR points to consider on the use of immunomodulatory therapies in COVID-19 126
Duration of clinical remission and low disease activity impacts on quality of life and its domains in psoriatic arthritis patients: results from an Italian multicentre study 107
ASSESSING PRO-INFLAMMATORY PROPERTIES OF H-FERRITIN BY EX VIVO AND IN VITRO OBSERVATIONS 106
Association Between Minor Salivary Gland Biopsy During Sjӧgren's Syndrome and Serologic Biomarkers: A Systematic Review and Meta-Analysis 106
Clinical and subclinical atherosclerosis in patients with systemic sclerosis: an observational, multicentre study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) 102
Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment 100
Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study 99
Derivation and validation of four patient clusters in Still’s disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease Registry 96
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 95
Addressing the clinical unmet needs in primary Sjögren's Syndrome through the sharing, harmonization and federated analysis of 21 European cohorts 95
Cytokine storm syndrome in severe COVID-19 91
). IL-6 e TGF-b1 nel siero e nei sovranatanti di cellule mononucleate in pazienti con sclerosi sistemica (SSC). 90
A genetic variation located in the promoter region of the UPAR (CD87) gene is associated with the vascular complications of systemic sclerosis. 90
Correction to: Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study 89
Activation antigens and adhesion molecules expression on Vd1+ T cells in systemic sclerosis (SSc) 89
Aberrant cytokine expression and severity of the infiltrates are reverted by rituximab therapy in salivary glands of patients with Sjogren’s syndrome 87
EVIDENCE FOR REDUCED ANGIOGENESIS IN BONE MARROW (BM) IN SYSTEMIC SCLEROSIS (SSC) 85
Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets? 83
Clinical features and prognosis of COVID-19 in people with spinal cord injury: a case–control study 82
Association between clinical, histopathological and molecular features in primary Sjogren's Syndrome: a retrospective study 82
Incidence, prevalence and mortality of systemic sclerosis in Italy: a nationwide population-based study using administrative health data 81
Benefits of anakinra versus TNF inhibitors in rheumatoid arthritis and type 2 diabetes: long-term findings from participants furtherly followed-up in the TRACK study, a multicentre, open-label, randomised, controlled trial 78
Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: A new potential target for antifibrotic therapy 76
Cardiovascular disease in primary sjögren’s syndrome 73
SARS-CoV-2 infection in patients with primary Sjögren syndrome: characterization and outcomes of 51 patients 73
Interstitial Lung Disease and Pulmonary Damage in Primary Sjögren's Syndrome: A Systematic Review and Meta-Analysis 70
The specialized pro-resolving lipid mediator Protectin D1 affects macrophages differentiation and activity in Adult-onset Still's disease and COVID-19, two hyperinflammatory diseases sharing similar transcriptomic profiles 70
The Effect of Ketogenic Diet on Inflammatory Arthritis and Cardiovascular Health in Rheumatic Conditions: A Mini Review 67
Pain catastrophizing negatively impacts drug retention rate in patients with Psoriatic Arthritis and axial Spondyloarthritis: results from a 2-years perspective multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica) study 64
Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers 60
Association between Patient Acceptable Symptom State and disease activity in psoriatic arthritis is disrupted by confounders, including comorbid fibromyalgia 58
Mortality in tocilizumab-treated patients with COVID-19: a systematic review and meta-analysis 57
The economic burden of fibromyalgia: A systematic literature review 57
Correction: Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry 56
Macrophage activation syndrome in patients affected by adult-onset still disease: Analysis of survival rates and predictive factors in the Gruppo Italiano di Ricerca in reumatologia clinica e sperimentale cohort 56
Unenhanced Cardiac Magnetic Resonance may improve detection and prognostication of an occult heart involvement in asymptomatic patients with systemic sclerosis 55
Absent or suboptimal response to booster dose of COVID-19 vaccine in patients with autoimmune systemic diseases 55
The Vessels Contribute to Fibrosis in Systemic Sclerosis 53
Mediterranean diet and Psoriatic Arthritis activity: a multicenter cross-sectional study 53
EULAR Textbook on Rheumatic Diseases – Third Edition (2018) 53
Development and Implementation of the AIDA International Registry for Patients With VEXAS Syndrome 52
The evaluation of type I interferon score in dermatomyositis, a systematic review and a meta-analysis 51
Where are we going in the management of interstitial lung disease in patients with systemic sclerosis? 50
A phase 2 randomized, double-blind, placebo-controlled, proof-of-concept study of oral seletalisib in primary Sjögren's syndrome 50
Development and implementation of the AIDA International Registry for patients with Behçet's disease 49
Shulman, malattia di 49
IL-36α axis is modulated in patients with primary Sjogren's Syndrome. 48
Beyond the joints, the extra-articular manifestations in rheumatoid arthritis 48
Interstitial lung disease in systemic sclerosis: Pathophysiology and therapy 47
Long-term retention rate of anakinra in adult onset Still’s disease and predictive factors for treatment response 46
THU0582 Prognostic Factors of Macrophage Activation Syndrome in Adults: Analysis of 40 Cases in 2 Tertiary Referral Centers 46
Interferenza farmacologica "in vitro" sulla aderenza batterica agli spermatozoi 46
PTP4A1 promotes TGFβ signaling and fibrosis in systemic sclerosis 46
The assessment of atlantoaxial joint involvement in patients with rheumatoid arthritis, results from an observational “real-life” study 45
Sociodemographic factors in fibromyalgia: results from the Italian Fibromyalgia Registry 45
Serological biomarkers of b-cell lymphoproliferative disorders in patients with primary sjögren’s syndrome: retrospective study in a large italian cohort 45
Co-Occurrence of Anti-Synthetase Syndrome and Sjögren Disease: A Case-Based Review 44
Clinical targeted treatment in Sjogren's disease: A systematic literature review for an evidence-based medicine approach 44
il sistema immunitario 44
Occurrence and predictive factors of high blood pressure, type 2 diabetes, and metabolic syndrome in rheumatoid arthritis: findings from a 3-year, multicentre, prospective, observational study 44
Autoimmune screening before adenovirus vector-based DNA vaccine in women may avoid underuse for all the subjects 44
Multicenter Validation of the DETAIL Questionnaire for the Screening of Spondyloarthritis in Patients With Inflammatory Bowel Diseases 43
The assessment of the drug retention rate of secukinumab in patients with psoriatic arthritis in a real-life multicentre cohort 43
Attività NK ed ADCC in pazienti con malattie infiammatorie intestinali (IBD). 43
Effects of cadmium (Cd) and zinc (Zn) ions on lymphocyte cultures. 43
Immunopharmacological profile of sebatic acid, a candidate for total parenteral nutrition. 43
Novel biomarker for pulmonary vascular disease in systemic sclerosis patients 42
Factors influencing the patient evaluation of injection experience with the SmartJect autoinjector in rheumatoid arthritis. 42
Ultrastructural alterations of refrigerated vs cryopreserved human semen 42
SCLERODERMA FIBROBLASTS SUPPRESS ANGIOGENESIS VIA TGF-beta/CAVEOLIN-DEPENDENT SECRETION OF PIGMENTED EPITHELIUM DERIVED FACTOR: TGF-beta RECEPTOR INHIBITORS AS A NOVEL THERAPEUTIC TARGET FOR THE TREATMENT OF SCLERODERMA 42
Macrophages with regulatory functions, a possible new therapeutic perspective in autoimmune diseases 41
Emergenze cliniche in corso di allergia al veleno di imenotteri. 41
IL-6 production from peripheral blood mononuclear cells (PBMC) of patients affected by progressive systemic sclerosis (PSS). 41
The kaleidoscope of neurological manifestations in primary Sjögren's syndrome 41
Prognostic factors of macrophage activation syndrome, at the time of diagnosis, in adult patients affected by autoimmune disease: Analysis of 41 cases collected in 2 rheumatologic centers 41
Jejunoileal bypass as the main procedure in the onset of immune-related conditions: the model of BADAS. 41
Totale 9.020
Salva come PNG Salva come JPEG
Categoria #
all - tutte 213.704
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 213.704
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022648 0 5 29 4 7 2 4 4 55 29 19 490
2022/2023318 5 15 11 28 73 13 6 7 10 11 130 9
2023/20241.786 60 216 61 144 198 839 32 85 17 51 40 43
2024/202510.867 230 179 617 113 109 364 242 64 1.422 1.088 3.012 3.427
2025/20267.621 1.556 496 1.216 2.243 456 944 710 0 0 0 0 0
Totale 21.240